Switzerland Pharmaceutical and Medical Goods Expenditure Share (2024)
Switzerland's Pharmaceutical and Medical Goods Expenditure Share: 14.5 % of current health expenditure in 2024, +0.4pp YoY.
Switzerland (2024)
14.5
% of current health expenditure
+0.4pp YoY
YoY Change
+0.4pp
percentage points
Trend
up
Series length
15
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 14.5 | +0.4pp |
| 2023 | 14.1 | -0.3pp |
| 2022 | 14.4 | +0.4pp |
| 2021 | 14 | -0.2pp |
| 2020 | 14.2 | unchanged |
| 2019 | 14.2 | unchanged |
| 2018 | 14.2 | +0.1pp |
| 2017 | 14.1 | +0.1pp |
| 2016 | 14 | +0.1pp |
| 2015 | 13.9 | unchanged |
| 2014 | 13.9 | -0.1pp |
| 2013 | 14 | -0.4pp |
| 2012 | 14.4 | -0.2pp |
| 2011 | 14.6 | -0.4pp |
| 2010 | 15 | n/a |
About this Dataset
Switzerland recorded 14.5 % of current health expenditure in 2024. The latest change was +0.4pp. Across 2010–2024 the series ranges from 13.9 % of current health expenditure in 2015 to 15 % of current health expenditure in 2010.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Switzerland.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Switzerland. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2010–2024 (15 observations).
The series peaked at 15 % of current health expenditure in 2010 and reached its lowest recorded value of 13.9 % of current health expenditure in 2015. The latest reading is 14.5 % of current health expenditure in 2024. The latest change was +0.4pp.